These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36592458)

  • 21. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Viswanathan M; Reddy S; Berkman N; Cullen K; Middleton JC; Nicholson WK; Kahwati LC
    JAMA; 2018 Jun; 319(24):2532-2551. PubMed ID: 29946734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoporosis: what's new and on the horizon.
    Silva BC; Costa AG; Cusano NE; Bilezikian JP
    Clin Obstet Gynecol; 2013 Dec; 56(4):730-8. PubMed ID: 24036482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New bone density conservation agents for osteoporosis under research and development: ED-71].
    Hagino H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():454-8. PubMed ID: 18161148
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of comparative effectiveness of treatments to prevent fractures.
    Karis R
    Ann Intern Med; 2008 Jun; 148(11):886; author reply 887. PubMed ID: 18519942
    [No Abstract]   [Full Text] [Related]  

  • 25. Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY
    Osteoporos Int; 2018 Jul; 29(7):1505-1510. PubMed ID: 29869039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Male osteoporosis].
    Andersson S; Välimäki M
    Duodecim; 2009; 125(10):1109-16. PubMed ID: 19585908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of comparative effectiveness of treatments to prevent fractures.
    Black DM; Boonen S; Delmas P; Lyles KW
    Ann Intern Med; 2008 Jun; 148(11):885-6; author reply 887. PubMed ID: 18519940
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnosis and treatment of pediatric osteoporosis.
    Bachrach LK
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):454-60. PubMed ID: 25232753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium and vitamin D for osteoporotic fracture prevention.
    Carmona RJ; Adachi JD
    Pol Arch Med Wewn; 2007 Oct; 117(10):441-2. PubMed ID: 18320782
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteoporosis: What about men?
    Farford B; Balog J; Jackson KD; Montero D
    J Fam Pract; 2015 Sep; 64(9):542-52. PubMed ID: 26546951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male osteoporosis: who should be treated and how?
    Biver E; Borg S; Chopin F; Hoppé E; Morel G; Cortet B
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S202-7. PubMed ID: 22153671
    [No Abstract]   [Full Text] [Related]  

  • 33. Bisphosphonates and lower mortality risk: when it sounds to be good to be true ….
    Leslie WD
    Osteoporos Int; 2019 Dec; 30(12):2365-2367. PubMed ID: 31630216
    [No Abstract]   [Full Text] [Related]  

  • 34. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of comparative effectiveness of treatments to prevent fractures.
    Rosen H
    Ann Intern Med; 2008 Jun; 148(11):884; author reply 887. PubMed ID: 18519939
    [No Abstract]   [Full Text] [Related]  

  • 36. [Osteoporosis treatment].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2006 Jan; 2(47):47-51. PubMed ID: 16465945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of treatments for osteoporosis on mortality.
    Grey A; Bolland MJ
    Osteoporos Int; 2013 Jan; 24(1):1-6. PubMed ID: 23076683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
    Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
    Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis medication after fracture in older adults: an administrative data analysis.
    Yamamoto Y; Chiba T; Dohmae S; Higashi K; Nakazawa A
    Osteoporos Int; 2021 Jun; 32(6):1245-1246. PubMed ID: 33914105
    [No Abstract]   [Full Text] [Related]  

  • 40. "Evidence-based" or "logic-based" medicine?: response to Blank et al.
    Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
    Osteoporos Int; 2010 Oct; 21(10):1685-6. PubMed ID: 20464544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.